ID   NEUA_HUMAN              Reviewed;         434 AA.
AC   Q8NFW8; Q96AX5; Q9NQZ0;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   15-MAR-2017, entry version 126.
DE   RecName: Full=N-acylneuraminate cytidylyltransferase;
DE            EC=2.7.7.43;
DE   AltName: Full=CMP-N-acetylneuraminic acid synthase;
DE            Short=CMP-NeuNAc synthase;
GN   Name=CMAS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, ENZYME
RP   ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=11602804; DOI=10.1023/A:1012452705349;
RA   Lawrence S.M., Huddleston K.A., Tomiya N., Nguyen N., Lee Y.C.,
RA   Vann W.F., Coleman T.A., Betenbaugh M.J.;
RT   "Cloning and expression of human sialic acid pathway genes to generate
RT   CMP-sialic acids in insect cells.";
RL   Glycoconj. J. 18:205-213(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bouquin T., Mundy J.;
RT   "Human mRNA for CMP-N-acetylneuraminic acid synthase.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-16; 38-52; 189-200; 307-316 AND 384-399,
RP   ACETYLATION AT MET-1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Lourenco F., Olson M.F.;
RL   Submitted (AUG-2009) to UniProtKB.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the activation of N-acetylneuraminic acid
CC       (NeuNAc) to cytidine 5'-monophosphate N-acetylneuraminic acid
CC       (CMP-NeuNAc), a substrate required for the addition of sialic
CC       acid. Has some activity toward NeuNAc, N-glycolylneuraminic acid
CC       (Neu5Gc) or 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN).
CC   -!- CATALYTIC ACTIVITY: CTP + N-acylneuraminate = diphosphate + CMP-N-
CC       acylneuraminate. {ECO:0000269|PubMed:11602804}.
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate metabolism.
CC   -!- SUBUNIT: Homotetramer; the active enzyme is formed by a dimer of
CC       dimers.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11602804}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NFW8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NFW8-2; Sequence=VSP_012764;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed in pancreas,
CC       kidney, liver, skeletal muscle, lung, placenta, brain, heart,
CC       colon, PBL, small intestine, ovary, testis, prostate, thymus and
CC       spleen. {ECO:0000269|PubMed:11602804}.
CC   -!- DOMAIN: The BC2 (basic cluster 2) motif is necessary and
CC       sufficient for the nuclear localization and contains the catalytic
CC       active site. The localization in the nucleus is however not
CC       required for the enzyme activity (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the CMP-NeuNAc synthase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF397212; AAM90580.1; -; mRNA.
DR   EMBL; AF271388; AAF76203.1; -; mRNA.
DR   EMBL; AK022927; BAB14311.1; -; mRNA.
DR   EMBL; AL832975; CAH56346.1; -; mRNA.
DR   EMBL; BC016609; AAH16609.1; -; mRNA.
DR   CCDS; CCDS8696.1; -. [Q8NFW8-1]
DR   RefSeq; NP_061156.1; NM_018686.5. [Q8NFW8-1]
DR   UniGene; Hs.311346; -.
DR   ProteinModelPortal; Q8NFW8; -.
DR   SMR; Q8NFW8; -.
DR   BioGrid; 120993; 20.
DR   IntAct; Q8NFW8; 7.
DR   STRING; 9606.ENSP00000229329; -.
DR   DrugBank; DB02485; Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid.
DR   iPTMnet; Q8NFW8; -.
DR   PhosphoSitePlus; Q8NFW8; -.
DR   SwissPalm; Q8NFW8; -.
DR   BioMuta; CMAS; -.
DR   DMDM; 68059539; -.
DR   EPD; Q8NFW8; -.
DR   MaxQB; Q8NFW8; -.
DR   PaxDb; Q8NFW8; -.
DR   PeptideAtlas; Q8NFW8; -.
DR   PRIDE; Q8NFW8; -.
DR   Ensembl; ENST00000229329; ENSP00000229329; ENSG00000111726. [Q8NFW8-1]
DR   Ensembl; ENST00000534981; ENSP00000446239; ENSG00000111726. [Q8NFW8-2]
DR   GeneID; 55907; -.
DR   KEGG; hsa:55907; -.
DR   UCSC; uc001rfm.5; human. [Q8NFW8-1]
DR   CTD; 55907; -.
DR   DisGeNET; 55907; -.
DR   GeneCards; CMAS; -.
DR   HGNC; HGNC:18290; CMAS.
DR   HPA; HPA039905; -.
DR   MalaCards; CMAS; -.
DR   MIM; 603316; gene.
DR   neXtProt; NX_Q8NFW8; -.
DR   OpenTargets; ENSG00000111726; -.
DR   PharmGKB; PA38519; -.
DR   eggNOG; ENOG410IJVA; Eukaryota.
DR   eggNOG; COG1083; LUCA.
DR   eggNOG; COG1778; LUCA.
DR   GeneTree; ENSGT00390000004237; -.
DR   HOGENOM; HOG000284760; -.
DR   HOVERGEN; HBG052605; -.
DR   InParanoid; Q8NFW8; -.
DR   KO; K00983; -.
DR   OMA; QVHRRSP; -.
DR   OrthoDB; EOG091G0W03; -.
DR   PhylomeDB; Q8NFW8; -.
DR   TreeFam; TF324840; -.
DR   Reactome; R-HSA-4085001; Sialic acid metabolism.
DR   UniPathway; UPA00628; -.
DR   ChiTaRS; CMAS; human.
DR   GeneWiki; CMAS_(gene); -.
DR   GenomeRNAi; 55907; -.
DR   PRO; PR:Q8NFW8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111726; -.
DR   CleanEx; HS_CMAS; -.
DR   ExpressionAtlas; Q8NFW8; baseline and differential.
DR   Genevisible; Q8NFW8; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008781; F:N-acylneuraminate cytidylyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006054; P:N-acetylneuraminate metabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR003329; Cytidylyl_trans.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF02348; CTP_transf_3; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Methylation; Nucleotidyltransferase;
KW   Nucleus; Reference proteome; Transferase.
FT   CHAIN         1    434       N-acylneuraminate cytidylyltransferase.
FT                                /FTId=PRO_0000213199.
FT   MOTIF        15     31       BC1 motif.
FT   MOTIF       200    206       BC2 motif.
FT   MOTIF       269    276       BC3 motif.
FT   ACT_SITE    201    201       {ECO:0000250}.
FT   BINDING      52     52       Substrate. {ECO:0000250}.
FT   BINDING      62     62       Substrate. {ECO:0000250}.
FT   BINDING     111    111       Substrate. {ECO:0000250}.
FT   BINDING     120    120       Substrate. {ECO:0000250}.
FT   BINDING     122    122       Substrate. {ECO:0000250}.
FT   BINDING     143    143       Substrate. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES      37     37       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q99KK2}.
FT   MOD_RES      52     52       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q99KK2}.
FT   VAR_SEQ     264    434       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012764.
FT   CONFLICT    396    396       T -> Y (in Ref. 1; AAM90580).
FT                                {ECO:0000305}.
SQ   SEQUENCE   434 AA;  48379 MW;  B303B6647EF81A3A CRC64;
     MDSVEKGAAT SVSNPRGRPS RGRPPKLQRN SRGGQGRGVE KPPHLAALIL ARGGSKGIPL
     KNIKHLAGVP LIGWVLRAAL DSGAFQSVWV STDHDEIENV AKQFGAQVHR RSSEVSKDSS
     TSLDAIIEFL NYHNEVDIVG NIQATSPCLH PTDLQKVAEM IREEGYDSVF SVVRRHQFRW
     SEIQKGVREV TEPLNLNPAK RPRRQDWDGE LYENGSFYFA KRHLIEMGYL QGGKMAYYEM
     RAEHSVDIDV DIDWPIAEQR VLRYGYFGKE KLKEIKLLVC NIDGCLTNGH IYVSGDQKEI
     ISYDVKDAIG ISLLKKSGIE VRLISERACS KQTLSSLKLD CKMEVSVSDK LAVVDEWRKE
     MGLCWKEVAY LGNEVSDEEC LKRVGLSGAP ADACSTAQKA VGYICKCNGG RGAIREFAEH
     ICLLMEKVNN SCQK
//
